DOI: 10.1055/s-00000030

Der Klinikarzt


Wilke HJ, Van Cutsem E, Oh SC et al.
RAINBOW: A global, phase III, randomized, double-blind study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in the treatment of metastatic gastroesophageal junction (GEJ) and gastric adenocarcinoma following disease progression on first-line platinum- and fluoropyrimidine-containing combination therapy rainbow IMCL CP12-0922 (I4T-IE-JVBE).

J Clin Oncol 2014; (Suppl. 03)

Download Bibliographical Data

Search in: